Healthy volunteers test new injection device for risankizumab
NCT ID NCT07007091
First seen Jan 04, 2026 · Last updated May 22, 2026 · Updated 18 times
Summary
This study tested how well the drug risankizumab enters the body when given through a wearable injector compared to a standard syringe. It involved 260 healthy adults and measured drug levels in the blood and any side effects. The goal was to see if the new device works as well as the syringe, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Acpru /Id# 276043
Grayslake, Illinois, 60030, United States
-
Cpmi /Id# 276490
Miami, Florida, 33172, United States
-
PPD Phase I Clinic /ID# 276525
Austin, Texas, 78744, United States
-
Ppd - Las Vegas Research Unit /ID# 276565
Las Vegas, Nevada, 89113, United States
Conditions
Explore the condition pages connected to this study.